Your account is not claimed yet. You can sign up with ORCID to claim your account.

Michał Marczyk (Michal Marczyk)

ResearcherID Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 13

Top Venues

NPJ breast cancer

Cancers

Journal of personalized medicine

Journal of the National Cancer Institute

Yale University School of Medicine

Silesian University of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yale University School of Medicine Dec 1o 2017

United States

Associate Research Scientist :: Internal Medicine

Education History

Silesian University of Technology Oct 1o 2008 - Sep 30o 2013

Poland

PHD :: Automatic Control, Electronics and Computer Science

Publications

Michał Marczyk, Chunxiao Fu, Rosanna Lau, Lili Du, Alexander J Trevarton, Bruno V Sinn, Rebekah E Gould, Lajos Pusztai, Christos Hatzis, William Fraser Symmans
Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing. Cancer cytopathology (2023)
Gloria H Sura, Kevin Tran, Chunxiao Fu, Lili Du, Michał Marczyk, Rebekah E Gould, Eveline Chen, Amy M Tasto, Agata A Tinnirello, W Fraser Symmans
Pre-analytical effects on whole transcriptome and targeted RNA sequencing analysis in cytology: The effects of prolonged time in storage of effusion specimens prior to preservation. Cytopathology : official journal of the British Society for Clinical Cytology (2023)
Michał Marczyk, Vignesh Gunasekharan, David Casadevall, Tao Qing, Julia Foldi, Raghav Sehgal, Naing Lin Shan, Kim R M Blenman, Tess A O'Meara, Sheila Umlauf, Yulia V Surovtseva, Viswanathan Muthusamy, Jesse Rinehart, Rachel J Perry, Richard Kibbey, Christos Hatzis, Lajos Pusztai
Comprehensive Analysis of Metabolic Isozyme Targets in Cancer. Cancer research 82 (9) (2022)
Julia Foldi, Andrea Silber, Emily S Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michał Marczyk, Courtney Frederick, Trisha Burrello, Eiman Y Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L Rimm, Lajos Pusztai
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer. NPJ breast cancer 8 (1) (2022)
Tao Qing, Thomas Karn, Mariya Rozenblit, Julia Foldi, Michał Marczyk, Naing Lin Shan, Kim R M Blenman, Uwe Holtrich, Kevin Kalinsky, Funda Meric-Bernstam, Lajos Pusztai
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. NPJ breast cancer 8 (1) (2022)
Tao Qing, Hussein Mohsen, Vincent L Cannataro, Michał Marczyk, Mariya Rozenblit, Julia Foldi, Michael Murray, Jeffrey P Townsend, Yuval Kluger, Mark Gerstein, Lajos Pusztai
Cancer Relevance of Human Genes. Journal of the National Cancer Institute 114 (7) (2022)
Kim R M Blenman, Michał Marczyk, Thomas Karn, Tao Qing, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Y Ibrahim, Tristen Park, Andrea Silber, Denise M Wolf, Emily Reisenbichler, Carsten Denkert, Bruno Valentin Sinn, Mariya Rozenblit, Julia Foldi, David L Rimm, Sibylle Loibl, Lajos Pusztai
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Aleksandra Suwalska, Lukasz Zientek, Joanna Polańska, Michał Marczyk
Quantifying Spatial Heterogeneity of Tumor-Infiltrating Lymphocytes to Predict Survival of Individual Cancer Patients. Journal of personalized medicine 12 (7) (2022)
Gauri A Patwardhan, Michał Marczyk, Vikram B Wali, David F Stern, Lajos Pusztai, Christos Hatzis
Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations. NPJ breast cancer 7 (1) (2021)
Julia Foldi, Andrea Silber, Emily S Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michał Marczyk, Courtney Frederick, Trisha Burrello, Eiman Y Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L Rimm, Lajos Pusztai
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer. NPJ breast cancer 7 (1) (2021)
Tao Qing, Hussein Mohsen, Michał Marczyk, Yixuan Ye, Tess O'Meara, Hongyu Zhao, Jeffrey P Townsend, Mark Gerstein, Christos Hatzis, Yuval Kluger, Lajos Pusztai
Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden. Nature communications 11 (1) (2020)
Michał Marczyk, Gauri A Patwardhan, Jun Zhao, Rihao Qu, Xiaotong Li, Vikram B Wali, Abhishek K Gupta, Manoj M Pillai, Yuval Kluger, Qin Yan, Christos Hatzis, Lajos Pusztai, Vignesh Gunasekharan
Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells. Cancers 12 (9) (2020)
Kimi Drobin, Michał Marczyk, Martin Halle, Daniel Danielsson, Anna Papiez, Traimate Sangsuwan, Annika Bendes, Mun-Gwan Hong, Ulrika Qundos, Mats Harms-Ringdahl, Peter Wersäll, Joanna Polańska, Jochen M Schwenk, Siamak Haghdoost
Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer. Cancers 12 (3) (2020)

Michał Marczyk.css-eqlu8i{font-size:small;padding-left:4px;} (Michal Marczyk)

Publication Activity (10 Years)

Top Topics

Top Venues

Michał Marczyk (Michal Marczyk)